Foresite Capital Management IV, LLC Portfolio
Auto-discovered active 13F filer.
SEC 13F CIK: 0001704132
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2024 · 4 positions · Total reported value $108.80M · Top-10 concentration 100.0% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 28.6% · 1 new · 0 cut · 1 exited
Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
In its Q4 2024 13F filing, Foresite Capital Management IV, LLC disclosed 4 equity positions with a combined reported value of $108.80M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q4 2024 were PHVS ($84.31M), KURA ($15.04M), LYEL ($5.33M). By sector, the heaviest allocations are Health Care 100.0%.
Versus the prior quarter, Foresite Capital Management IV, LLC opened 1 new positions, trimmed 0 and fully exited 1, a turnover rate of 28.6% of positions. The portfolio's overlap with the prior quarter was 80% of names.
Of the 1 positions fully exited versus the prior quarter, the largest were SNDX ($16.84M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q4 2024)
No new positions this quarter.
Fully Exited (vs previous quarter)
- SNDX SYNDAX PHARMACEUTICALS INC · prev qtr: $16.84M
Insider Transactions (Form 4)
Latest Foresite Capital Management IV, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Foresite Capital Management IV, LLC files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 6 positions worth $252.03M in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).
Portfolio Structure
- 6 positions · $252.03M reported value (Q3 2026)
- Top 10 holdings = 100.0% of reported value
- Largest position: PHVS (PHARVARIS N V) at 60.1%
- Average position size: $42.01M
Sector Tilt
- Health Care 100.0%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q3 2026: 1 new, 1 exited
- 5 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
FAQ
What did Foresite Capital Management IV, LLC buy in 2024-Q4?
In its 2024-Q4 13F filing, Foresite Capital Management IV, LLC reported 4 equity positions worth $108.80M in aggregate; its largest disclosed positions were PHVS ($84.31M), KURA ($15.04M), LYEL ($5.33M).
How large is Foresite Capital Management IV, LLC's portfolio?
Foresite Capital Management IV, LLC reported $108.80M of long equity holdings across 4 positions as of 2024-Q4. Top-10 holdings account for 100.0% of reported value.
What is Foresite Capital Management IV, LLC's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.